Previous reports suggested that sharing outpatient information during chemotherapy is very important for managing pharmaceutical usage between community pharmacies and hospitals. We herein examined using a questionnaire survey whether pharmaceutical management for outpatient chemotherapy is desired by community and hospital pharmacists. The response rates were 44.3％ (133/300) for pharmacists in community pharmacies and 53.7％ (161/300) for pharmacists in hospitals. Prescriptions for outpatients during chemotherapy were issued at 88.2％ of the hospitals. Currently, 28.9％ of hospital pharmacists rarely provide pharmaceutical care, such as patient guidance and adverse eŠect monitoring, for outpatients receiving oral chemotherapy. Furthermore, whereas 93.7％ of hospital pharmacists conducted prescription audits based on the chemotherapy regimen, audits were only performed by 14.8％ of community pharmacists. Thus, outpatients, particularly those on oral regimens, were unable to receive safe pharmaceutical care during chemotherapy. Community pharmacists suggested that hospital pharmacists should use``medication notebooks'' and disclose prescription information when providing clinical information to community pharmacists. They also suggested sending clinical information to hospital pharmacists by fax. On the other hand, hospital pharmacists suggested the use of``medication notebooks'' and electronic medical records when providing clinical information to community pharmacists. In addition, they suggested for community pharmacists to use electronic medical records when providing clinical information to hospital pharmacists. As there may be diŠerences in opinion between community and hospital pharmacists, mutual preliminary communication is important for successful outpatient chemotherapy. 日本病院薬剤師会平成 24 年度学術委員会学術第 3 小委員会では，がん診療連携拠点病院において
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